Ellen Tsai

Dr. Ellen Tsai

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2021 in Nature Genetics
Verified
Journal Article
Open access
PDF file
WRWouter van Rheenen
Wouter van Rheenen
RSRick A. A. van der Spek
Rick A. A. van der Spek
MBMark K. Bakker
Mark K. Bakker
JVJoke J. F. A. van Vugt
Joke J. F. A. van Vugt
PHPaul J. Hop
Paul J. Hop
JVJan H. Veldink
Jan H. Veldink
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a lifetime risk of one in 350 people and an unmet need for disease-modifying therapies. We conducted a cross-ancestry genome-wide association study (GWAS) including 29,612 patients with ALS and 122,656 controls, which identified 15 risk loci. When combined with 8,953 individuals with whole-genome sequencing (6,538 patients, 2,415 controls) and a large cortex-derived expression quantitative trait locus (eQTL) dataset (MetaBrain), analyses revealed locus-specific genetic architectures in which we prioritized genes either through rare variants, short tandem repeats or regulatory effects. ALS-associated risk loci were shared with multiple traits within the neurodegenerative spectrum but with distinct enrichment patterns across brain regions and cell types. Of the environmental and lifestyle risk factors obtained from the literature, Mendelian randomization analyses indicated a causal role for high cholesterol levels. The combination of all ALS-associated signals reveals a role for perturbations in vesicle-mediated transport and autophagy and provides evidence for cell-autonomous disease initiation in glutamatergic neurons.

28 June 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JSJoseph D. Szustakowski
Joseph D. Szustakowski
SBSuganthi Balasubramanian
Suganthi Balasubramanian
EKErika Kvikstad
Erika Kvikstad
SKShareef Khalid
Shareef Khalid
PBPaola G. Bronson
Paola G. Bronson
JRJeffrey G. Reid
Jeffrey G. Reid

23 February 2023 in Nature Genetics
Verified
Journal Article
Open access
PDF file
NKNiek de Klein
Niek de Klein
ETEllen Tsai
Ellen Tsai
MVMartijn Vochteloo
Martijn Vochteloo
DBDenis Baird
Denis Baird
YHYunfeng Huang
Yunfeng Huang
HWHarm-Jan Westra
Harm-Jan Westra
Identification of therapeutic targets from genome-wide association studies (GWAS) requires insights into downstream functional consequences. We harmonized 8,613 RNA-sequencing samples from 14 brain datasets to create the MetaBrain resource and performed cis- and trans-expression quantitative trait locus (eQTL) meta-analyses in multiple brain region- and ancestry-specific datasets (n ≤ 2,759). Many of the 16,169 cortex cis-eQTLs were tissue-dependent when compared with blood cis-eQTLs. We inferred brain cell types for 3,549 cis-eQTLs by interaction analysis. We prioritized 186 cis-eQTLs for 31 brain-related traits using Mendelian randomization and co-localization including 40 cis-eQTLs with an inferred cell type, such as a neuron-specific cis-eQTL (CYP24A1) for multiple sclerosis. We further describe 737 trans-eQTLs for 526 unique variants and 108 unique genes. We used brain-specific gene-co-regulation networks to link GWAS loci and prioritize additional genes for five central nervous system diseases. This study represents a valuable resource for post-GWAS research on central nervous system diseases.

23 February 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
PHPaul J. Hop
Paul J. Hop
RZRamona A.J. Zwamborn
Ramona A.J. Zwamborn
EHEilis Hannon
Eilis Hannon
GSGemma L. Shireby
Gemma L. Shireby
MNMarta F. Nabais
Marta F. Nabais
GSGeorge Davey Smith
George Davey Smith
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with an estimated heritability between 40 and 50%. DNA methylation patterns can serve as proxies of (past) exposures and disease progression, as well as providing a potential mechanism that mediates genetic or environmental risk. Here, we present a blood-based epigenome-wide association study meta-analysis in 9706 samples passing stringent quality control (6763 patients, 2943 controls). We identified a total of 45 differentially methylated positions (DMPs) annotated to 42 genes, which are enriched for pathways and traits related to metabolism, cholesterol biosynthesis, and immunity. We then tested 39 DNA methylation–based proxies of putative ALS risk factors and found that high-density lipoprotein cholesterol, body mass index, white blood cell proportions, and alcohol intake were independently associated with ALS. Integration of these results with our latest genome-wide association study showed that cholesterol biosynthesis was potentially causally related to ALS. Last, DNA methylation at several DMPs and blood cell proportion estimates derived from DNA methylation data were associated with survival rate in patients, suggesting that they might represent indicators of underlying disease processes potentially amenable to therapeutic interventions.

25 May 2023 in Nature Genetics
Verified
Journal Article
Open access
PDF file
CCChia-Yen Chen
Chia-Yen Chen
RTRuoyu Tian
Ruoyu Tian
TGTian Ge
Tian Ge
MLMax Lam
Max Lam
GSGabriela Sanchez-Andrade
Gabriela Sanchez-Andrade
HRHeiko Runz
Heiko Runz
Compelling evidence suggests that human cognitive function is strongly influenced by genetics. Here, we conduct a large-scale exome study to examine whether rare protein-coding variants impact cognitive function in the adult population (n = 485,930). We identify eight genes (ADGRB2, KDM5B, GIGYF1, ANKRD12, SLC8A1, RC3H2, CACNA1A and BCAS3) that are associated with adult cognitive function through rare coding variants with large effects. Rare genetic architecture for cognitive function partially overlaps with that of neurodevelopmental disorders. In the case of KDM5B we show how the genetic dosage of one of these genes may determine the variability of cognitive, behavioral and molecular traits in mice and humans. We further provide evidence that rare and common variants overlap in association signals and contribute additively to cognitive function. Our study introduces the relevance of rare coding variants for cognitive function and unveils high-impact monogenic contributions to how cognitive function is distributed in the normal adult population.

21 December 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
DADaniel J. Apicco
Daniel J. Apicco
ESEvgeny Shlevkov
Evgeny Shlevkov
CNCatherine L. Nezich
Catherine L. Nezich
DTDavid T. Tran
David T. Tran
EGEdward Guilmette
Edward Guilmette
WHWarren D. Hirst
Warren D. Hirst
Significance: Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease of aging, affecting approximately 10 million patients worldwide with no approved therapies to modify progression of disease. Further understanding of the cellular mechanisms contributing to the development of PD is necessary to discover therapies. Here, we characterize the role of a recently identified GWAS hit for sporadic PD, ITPKB, in the aggregation of α-synuclein, the primary pathological feature of disease. These results identify inhibition of inositol-1,4,5,-triphosphate (IP 3 )-mediated ER-to-mitochondria calcium release as a potential therapeutic approach for reducing neuropathology in PD.